(1)
Tahir Siddique; Sadaf Farzand; Marryam Khalid; Rizwan Ahmad; Kashif Aziz Ahmad; Muhammad Maqsood. Efficacy and Safety of Once-Weekly Semaglutide Versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial. JHWCR 2025, 3 (1), 1-8. https://doi.org/10.61919/qxt0b644.